AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 285: R1107-R1115, 2003. First published July 24, 2003; doi:10.1152/ajpregu.00320.2003
0363-6119/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/5/R1107    most recent
00320.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leury, B. J.
Right arrow Articles by Boisclair, Y. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leury, B. J.
Right arrow Articles by Boisclair, Y. R.

APPETITE, OBESITY AND METABOLISM

Effect of insulin and growth hormone on plasma leptin in periparturient dairy cows

Brian J. Leury,1 Lance H. Baumgard,2 Stephanie S. Block,2 Nthabisheng Segoale,2 Richard A. Ehrhardt,2 Robert P. Rhoads,2 Dale E. Bauman,2 Alan W. Bell,2 and Yves R. Boisclair2

1School of Agriculture and Food Systems, Institute of Land and Food Resources, University of Melbourne, Victoria, Australia, 3010; and 2Department of Animal Science, Cornell University, Ithaca, New York 14853-4801

Submitted 11 June 2003 ; accepted in final form 22 July 2003


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
After parturition, dairy cows suffer from an intense energy deficit caused by the onset of copious milk secretion and an inadequate increase in voluntary food intake. We previously showed that this energy deficit contributes to a decline in plasma leptin. This decline mirrors that of plasma insulin but is reciprocal to the profile of plasma growth hormone (GH), suggesting that both hormones may regulate plasma leptin in periparturient dairy cows. To study the role of insulin, hyperinsulinemic-euglycemic clamps were performed on six dairy cows in late pregnancy (LP, 31 days prepartum) and early lactation (EL, 7 days postpartum). Infusion of insulin (1 µg·kg body wt-1·h-1) caused a progressive rise in the plasma concentration of leptin that reached maximum levels at 24 h during both physiological states. At steady states, the absolute increase in plasma leptin was greater in LP than in EL cows (2.4 vs. 0.4 ng/ml). Insulin infusion increased leptin mRNA in adipose tissue during LP but not during EL. During lactation, mammary epithelial cells expressed leptin mRNA but insulin did not increase milk leptin output. In contrast, a 3-day period of GH administration had no effect on plasma leptin during LP or EL. Therefore, insulin increases plasma leptin in LP by stimulating adipose tissue synthesis but has only marginal effects in EL, when cows are in negative energy balance. Other factors, such as increased response of adipose tissue to {beta}-adrenergic signals, probably contribute to the reduction of plasma leptin in early lactating dairy cows.

pregnancy; lactation; hyperinsulinemic-euglycemic clamp

IN HIGH-YIELDING DAIRY COWS, the onset of lactation increases the total energy requirements by approximately fourfold, reflecting mostly the oxidative and milk precursor needs of the mammary gland (5, 6). Because the hyperphagia required to meet these additional demands develops slowly, shortfalls are met by mobilization of endogenous reserves and by shifting the pattern of nutrients used by nonmammary tissues (5, 6). Peripheral mechanisms orchestrating these adaptations have been studied extensively in ruminants, and they involve changes in the concentration and actions of hormones (51). For example, hypoinsulinemia and decreased insulin responsiveness of skeletal muscle and adipose tissue occur simultaneously in early lactation (7, 51). The sum effect of these adaptations is increased availability of glucose for the mammary gland where uptake is independent of insulin (5, 7). Some of these adaptations, such as hypoinsulinemia, also occur in lactating rodents and humans (40, 49).

The central nervous system (CNS) also plays important regulatory roles during this period and is receiving growing attention (45, 47, 49). This renewed interest reflects, in part, the recent discovery of leptin, a protein hormone synthesized almost exclusively by white adipose tissue (AT) (1, 29). In contrast to most other metabolic hormones, leptin acts predominantly on regions of the brain involved in the regulation of energy metabolism, such as the arcuate, ventromedial, and dorsomedial nuclei of the hypothalamus (1, 43, 45). Ahima and Flier (1) proposed that a fall in plasma leptin signals to the CNS that a state of energy insufficiency prevails in the periphery. Consistent with such a role during the transition period, plasma leptin is reduced around parturition in dairy cows (8, 31, 33). Moreover, early lactation and other conditions in which plasma leptin is low or absent share many adaptations such as depressed reproductive and immune function and higher metabolic efficiency (1, 5, 45, 49).

Factors responsible for the decline of plasma leptin in periparturient dairy cows have not been characterized. Adiposity cannot be the primary cause because plasma leptin falls before significant depletion of lipid reserves occurs (8). The decline, however, matches almost exactly the profile of plasma insulin at that time (6, 8). Insulin stimulates plasma leptin in simple-stomached species such as rodents and humans (1, 12), but its role in ruminants remains unknown (29). Moreover, growth hormone (GH), a hormone that attenuates many actions of insulin in bovine AT (19, 51), is also increased at parturition (6, 8). Therefore, the objectives of this study were to determine whether insulin and GH could regulate plasma leptin in periparturient dairy cows. Our studies show that insulin increases plasma leptin to a greater extent during pregnancy than during lactation and that GH is unlikely to play a major role.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Animals and design. The Cornell University Institutional Animal Care and Use Committee approved all experimental procedures. Only multiparous Holstein dairy cows were used.

Effect of insulin. Six cows were studied in late pregnancy (LP) and in early lactation (EL). At the start of these periods, cows averaged 31 ± 1.5 days prepartum (mean ± SE) and 7 ± 1.6 days postpartum, respectively, and weighed 626 ± 18 and 582 ± 15 kg, respectively. Cows were housed in a controlled environment (20°C, lights on 0500-2100) and fed a total mixed ration (TMR). Cows were fed according to recommended feeding standards (39). The TMR contained 1.56 Mcal of net energy for lactation (NEL) and 140 g crude protein (CP)/kg dry matter (DM) during LP and 1.58 Mcal NEL and 198 g CP/kg DM during EL. The TMR was offered ad libitum in 12 bihourly meals with water available at all times. During EL, cows also consumed a daily allowance of long-stem hay (3.6 kg containing 1.23 Mcal NEL and 144 g CP/kg DM). After parturition, cows were milked twice daily at 0600 and 1800.

Hyperinsulinemic-euglycemic clamps were performed by previously described procedures (22, 35). Briefly, cows were fitted with chronic indwelling catheters in each external jugular vein. Starting the next day (31 days prepartum during LP and 7 days postpartum during EL), basal conditions were characterized by taking blood samples over 66 h, followed by biopsies of subcutaneous AT from the tailhead region (8). Biopsied tissue was snap frozen in liquid nitrogen and stored at -80°C. Immediately after biopsy, insulin was infused at the rate of 1 µg·kg body wt-1·h-1 for 96 h during LP and for 48 h during EL. Infusates were prepared by diluting bovine pancreatic insulin (lot 615-70N-80, 26.6 IU/mg; Lilly Research Laboratories, Indianapolis, IN) in sterile saline with individual cow plasma as a carrier (2.5% vol/vol). The concentration of blood glucose was determined at frequent intervals (5-15 min) for the first 2-3 h and hourly thereafter with a Surestep glucometer (Lifescan, Milpitas, CA). Plasma glucose was maintained to the concentration observed during the basal period by varying the rate of intrajugular infusion of a glucose solution (50% wt/vol dextrose solution; Abbott Laboratories, Morgan Hills, CA). Blood samples were taken during the basal period and every 4 h during insulin infusion. After addition of heparin (10 IU/ml), plasma was obtained by centrifugation and stored at -20°C until being analyzed for hormones and metabolites. A second AT biopsy was obtained just before the insulin infusion was discontinued.

Source of mammary tissue and cells. Mammary gland and subcutaneous AT were obtained at death from lactating dairy cows and immediately frozen at -80°C. For isolation of mammary epithelial cells, parenchymal tissue was dissected from the mammary glands of additional EL dairy cows. Mammary epithelial cells were isolated by digestion with a mixture of collagenase, hyaluronidase, and elastase, followed by gradient centrifugation (34). This procedure yields primarily mammary epithelial cells (>95% of isolated cells), as shown by morphology and expression of milk protein genes and epithelial cell markers when cultured in vitro (34). Isolated cells were frozen immediately in liquid nitrogen until total RNA was prepared.

Effect of GH. Twelve cows were used in the period from 5 wk prepartum to 5 wk postpartum (weeks -5 to +5 relative to parturition). They were housed in individual tie stalls and fed a TMR ad libitum once daily. Nutrient composition of the TMR varied according to physiological state, with respective NEL and CP content of 1.36 Mcal and 130 g/kg DM during week -5, 1.56 Mcal and 141 g/kg DM between week -4 and parturition, and 1.72 Mcal and 179 g/kg DM after parturition. Cows were randomly allocated to a control or a GH group. The GH group received a daily injection of recombinant bovine GH bovine somatotropin (bST)], 45 mg/injection im; lot 96J-B5128-002, Monsanto, St. Louis, MO] on three consecutive days during weeks -5, -2, +1, and +5. Injections were initiated on the second day of each week, corresponding to days -30 ± 4, -13 ± 2, +2, and +30; variation during pregnancy reflects difference between predicted and actual time of parturition. By this mode of administration, GH-induced changes in insulin secretion and AT occur within 1 day of injection and persist for over 24 h after last administration (26, 52). Blood samples were obtained immediately before GH administration (day 0) and the day after the last injection (day 4). Sampling was by coccygeal venipuncture between 1000 and 1130. Control cows were sampled on the same day of each week. Plasma was prepared immediately and frozen at -20°C until analyzed. Cows were weighed at weekly intervals throughout the experiment and milked twice daily at 1130 and 2330 during lactation.

Whole body energetics. Individual feed intakes were recorded on a daily basis. Feed samples were collected weekly and analyzed for nutrient and chemical composition (Dairy One Cooperative, Ithaca, NY). Milk was weighed and sampled at each milking. Individual milk samples (insulin experiment) or weekly composites (GH experiment) were analyzed for protein, fat, and lactose content by infrared analysis (Dairy One Cooperative). Chemical composition of feeds and milk was used to estimate their energy content according to the National Research Council (NRC) (39). These data and body weights were used to calculate individual estimates of net energy balance (EB) on a daily basis (8, 26). To estimate changes in body fatness, two individuals independently assigned a body condition (BC) score (thin = 1, fat = 5) to each cow at the start and end of each period (8).

Analysis of gene expression. Total RNA was extracted from tissues and mammary epithelial cells by a modification of the guanidinium thiocyanate-phenol-chloroform method (8, 41). The concentration of total RNA was determined by absorbance at 260 nm, and its quality was verified by staining formaldehyde agarose gel with Syber Green II (Molecular Probes, Eugene, OR). Leptin mRNA was quantified by ribonuclease protection assay (RPA) with an RPA III kit [Ambion, Austin, TX] (8). The leptin probe corresponded to nt +64 to +316 (ATG, +1) of the bovine leptin cDNA and contained a sequence derived from the last two exons of the gene. The RPA also included a 10-fold molar excess of a low-specificity 18S probe generated from a DNA template (Ambion). Protected bands (253 bp for leptin, 80 bp for 18S) were resolved on 6% polyacrylamide, 7 M urea gels. Signals were quantified by phosphorimaging with a Fujix-Bio-Imaging Analyzer BAS 1000 (Fuji Medical Systems, Stanford, CT). When comparing leptin expression between mammary and adipose tissues, leptin signals were normalized to the mass of input RNA determined by A260.

Analysis of metabolites and hormones. Plasma glucose was measured by the glucose oxidase method and nonesterified fatty acids (NEFA) by the acyl-CoA synthetase/oxidase method (8). Plasma concentration of {beta}-hydroxybutyrate was assayed with the {beta}-hydroxybutyrate dehydrogenase method (kit 310-UV, Sigma, St. Louis, MO). Plasma concentrations of insulin and GH were determined by established RIAs (8). The concentration of leptin in plasma and milk was measured by a double-antibody bovine RIA developed in our laboratory (16). Milk leptin was assayed exactly as plasma, except that it was extensively mixed and sonicated before being diluted in assay buffer (27). RIA performed adequately with milk samples, as shown by parallel displacement curves of 125I-labeled bovine leptin, by serial dilution of bovine milk and standard, and by quantitative recovery of recombinant bovine leptin added to whole milk (>85%). The RIA for leptin has a sensitivity of 0.5 ng/ml and a range of 0.5-20 ng/ml. Inter- and intra-assay coefficients of variation for all metabolic and hormone assays averaged <8% and 9%, respectively.

Statistical methods. For the insulin study, energy-related variables during LP and EL were averaged over the last 48 h of the basal period and over the first 48 h of the clamp period. For hormones and metabolites, averages were calculated at steady state (entire basal period and the 36-48 h clamp period). Data were analyzed by a general linear model accounting for physiological state (STATE, LP vs. EL), insulin (INS, basal vs. hyperinsulinemia), and their interaction (STATE x INS) as fixed effects and animal as the random effect. Linear regression was used to assess the relationship of leptin concentration between plasma and milk. A repeated-measure model was used to analyze the effect of time and insulin on milk leptin concentration and output. For the GH study, the response was calculated for each variable as the difference between day 4 and day 0. Responses were analyzed by a model accounting for GH (GH, control vs. GH), time (TIME, weeks -5, -2, +1, and +5), and their interaction (GH x TIME) as fixed effects and animal as the random effect.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 DISCLOSURES
 REFERENCES
 
Insulin is a positive regulator of plasma leptin. Basal concentrations of plasma insulin and glucose were 60% and 20% lower in EL than in LP, respectively (Table 1; P < 0.001). Insulin infusion produced an almost immediate increase in plasma insulin concentration of ~2 ng/ml, irrespective of physiological state (Fig. 1 and Table 1; P < 0.001). When expressed relative to basal concentration, steady-state plasma insulin doubled during LP and nearly quadrupled during EL. During the clamps, plasma glucose concentration remained within 10% of basal concentration for both physiological states (Fig. 1), although slightly lower than basal state during the 36-48 h period of both clamps (Table 1; INS, P < 0.05). Despite lower plasma concentrations of glucose and insulin during EL, maintenance of euglycemia required significantly higher rates of glucose infusion (Fig. 1 and Table 2; P < 0.001). These data indicate that clamp conditions were rapidly achieved and maintained during both physiological states (Fig. 1).


View this table:
[in this window]
[in a new window]
  		Table 1. Response in plasma concentrations of hormones and metabolites to hyperinsulinemic-euglycemic clamp during late pregnancy and early lactation

 


View larger version (22K):
[in this window]
[in a new window]
  		Fig. 1. Profiles of glucose-related variables during hyperinsulinemiceuglycemic clamps. Six dairy cows in late pregnancy (31 ± 1.5 days prepartum) and early lactation (7 ± 1.6 days postpartum) were studied for 66 h under basal conditions and for 48 h during hyperinsulinemia-euglycemia. Dashed lines on blood glucose graph represent ±10% of baseline blood glucose. Pooled standard errors were 0.1 ng/ml for insulin, 1 mg/dl for plasma glucose, and 1.2 g/h for glucose infusion rate.

 

View this table:
[in this window]
[in a new window]
  		Table 2. Response in energy-related variables to hyperinsulinemic-euglycemic clamp during late pregnancy and early lactation

 

Under basal conditions, EL cows consumed 42% more dry matter (Table 2; P < 0.05) and tended to consume 33% more energy than LP cows (P = 0.07). This increase was still insufficient to meet the increased energy expenditures associated with milk production, as shown by the negative net EB during EL (P < 0.001). During EL, cows had lower BC scores and higher plasma NEFA concentrations (Tables 1 and 2; P < 0.05), indicating an increased use of body fat reserves. Despite this accelerated lipid mobilization, there was no evidence of subclinical or clinical ketogenesis, because plasma concentrations of {beta}-hydroxybutyrate did not differ between states (Table 1).

Hyperinsulinemia had no effect on voluntary feed and energy intake during LP but caused a 33% reduction in both variables during EL (Table 2; STATE x INS, P < 0.05). Despite this negative effect, the energy deficit of EL was not exacerbated (STATE x INS, P > 0.15). This is because the decreased feed intake during EL was also associated with a 15% reduction in milk energy output (INS, P < 0.05), reflecting combined reductions in yield as well as in fat and protein content of milk. The negative EB during the EL clamp persisted even after estimates were corrected for the caloric value of infused glucose (Table 2).

During both physiological states, plasma leptin started to rise within 4-8 h of insulin infusion and was maximally elevated after 24 h (Fig. 2); no further changes were detected over the next 24 h of hyperinsulinemia during EL or the next 72 h during LP (Fig. 2 and results not shown). During the 36-48 h interval of insulin infusion, plasma leptin was increased nearly 75% during LP but only 13% during EL (Table 1; STATE x INS, P < 0.05). This modest effect of insulin on plasma leptin during EL was in contrast to its equally effective inhibition of plasma {beta}-hydroxybutyrate during both states (P < 0.01) and to its exaggerated inhibition of plasma NEFA during EL (Table 1 and Fig. 2; STATE x INS, P < 0.05). We conclude that insulin is capable of increasing plasma leptin in dairy cows but this effect is attenuated considerably during EL.



View larger version (23K):
[in this window]
[in a new window]
  		Fig. 2. Profiles of leptin and nonesterified fatty acids (NEFA) during hyperinsulinemic-euglycemic clamps. Six dairy cows in late pregnancy (31 ± 1.5 days prepartum) and early lactation (7 ± 1.6 days postpartum) were studied for 66 h under basal condition and for 48 h during hyperinsulinemia-euglycemia. Pooled standard errors were 0.1 ng/ml for leptin and 8 µM for NEFA.

 

To examine the mechanism underlying the effects of insulin on plasma leptin, AT was obtained immediately at the end of the basal and clamp periods and assayed for abundance of leptin mRNA. Hyperinsulinemia increased the abundance of leptin mRNA during LP (Fig. 3; P < 0.05) but had no detectable effect during EL (results not shown).



View larger version (27K):
[in this window]
[in a new window]
  		Fig. 3. Effects of insulin on adipose tissue expression of the leptin gene during pregnancy. Six dairy cows in late pregnancy (31 ±1.5 days prepartum) were studied for 66 h under basal condition and for 96 h during hyperinsulinemia-euglycemia. Biopsies of adipose tissue were obtained at the end of the periods of basal measurement (-) and euglycemic hyperinsulinemia (+) when the plasma concentration of leptin averaged 3.2 and 5.3 ng/ml, respectively. Total RNA (2 µg) was analyzed simultaneously by a ribonuclease protection assay for the abundance of leptin and 18S ribosomal RNA. Bars represent the means ± SE of leptin signal normalized to the 18S signal. Bars with different letters differ at P < 0.05.

 

Secretion of leptin by bovine mammary gland is not increased by hyperinsulinemia in EL. In humans, the concentration of leptin is higher in milk than in plasma (27, 46). Moreover, epithelial cells derived from human breast tissue express the leptin gene and contain immunoreactive leptin (46). To determine whether the mammary gland is a site of synthesis in cattle, mammary tissue and isolated mammary epithelial cells were assayed for the presence of leptin mRNA. As shown in Fig. 4, leptin gene expression was readily detected in epithelial cells isolated from lactating mammary glands. A longer exposure was needed for detection of the leptin signal in mammary tissue, possibly reflecting the difficulty of obtaining representative samples of the whole gland in large animals. We conclude that, in the mammary gland of lactating dairy cows, epithelial cells are the major site of leptin synthesis. Leptin mRNA abundance in mammary epithelial cells, however, is considerably lower than that of AT (Fig. 4).



View larger version (19K):
[in this window]
[in a new window]
  		Fig. 4. Expression of the leptin gene in the mammary gland during lactation. Tissues were obtained at death from 2 (adipose tissue) or 3 (mammary gland) lactating dairy cows. Epithelial cells were obtained from 2 independent isolations by digestion of the parenchymal mammary compartment of 2 dairy cows. A: total RNA (either 3 or 30 µg as indicated) was analyzed by ribonuclease assay for the abundance of leptin mRNA. The arrow indicates the position of the single leptin signal of 253 bp (top). Before the ribonuclease assay was performed, 2 µg of each sample was evaluated for quality by denaturing agarose gel electrophoresis and Syber Green II staining (bottom). Lanes 1-6 are from a single autoradiogram exposed for 18 h. B: prolonged exposure (72 h) of autoradiogram corresponding to mammary tissue and epithelial cells (lanes 1-4 from A). The arrow indicates the position of the leptin signal. C: leptin signals obtained in A were quantified by phosphorimaging and corrected for the mass of RNA analyzed. Signals were expressed relative to the mean signal obtained in subcutaneous adipose tissue. Means ± SE with different letters differ at P < 0.05.

 

We also determined milk leptin content by RIA. On average, the concentration of leptin was approximately three times higher in milk than in plasma (Fig. 5). Plasma and milk leptin were not correlated during either the basal or the clamp periods. The milk leptin concentration appeared to increase over time during the clamp (INS x TIME, P < 0.08), but milk leptin output during the basal and clamp periods were identical (Fig. 5). We conclude that in EL the bovine mammary gland synthesizes leptin but that mammary secretion is not stimulated by insulin.



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 5. Mammary gland secretion of leptin during lactation. Six dairy cows in early lactation (7 ± 1.6 days postpartum) were studied for 66 h under basal conditions and for 48 h during hyperinsulinemic-euglycemic clamp. Cows were milked twice daily at 0600 and 1800. Aliquots of milk obtained at each milking (every 12 h) during basal and clamp periods were analyzed for the concentration of milk leptin by RIA. Left: concentrations of leptin in milk secreted over the last 24 h of the basal and clamp periods plotted against the mean plasma concentration of leptin during the corresponding time interval. Right: milk leptin concentration and yield during the 48-h period preceding (basal) and following the initiation of the hyperinsulinemic-euglycemic clamp (Clamp). The only effect approaching significance was the interaction between treatment and time (INS x TIME). Pooled SE for milk leptin concentration and yield were 0.4 ng/ml and 11.2 µg/12 h, respectively.

 

GH has no effect on plasma leptin in EL and LP. The reduction of plasma leptin observed during the transition from LP to EL is also associated with increased plasma GH (Table 1, P < 0.05; Ref. 8). We examined the possibility that GH might decrease plasma leptin in cows at 5 and 2 wk prepartum and again at 1 and 5 wk postpartum. At each time, cows receiving GH were sampled immediately before (day 0) and the day after a 3-day period of GH treatment (day 4). Control cows were sampled at identical times but were not treated.

The transition from pregnancy to lactation caused expected and identical changes in both groups of cows (i.e., onset of negative net EB and decreased plasma concentrations of insulin, glucose, and leptin; Fig. 6 and results not shown). As observed by others (52), GH treatment caused a significant increase in plasma insulin during pregnancy but not during lactation (Fig. 6; GH x TIME, P < 0.05). In contrast, GH had no effect on plasma leptin during either pregnancy or lactation. Therefore, the periparturient increase in plasma GH is unlikely to contribute to the postpartum reduction in plasma leptin.



View larger version (17K):
[in this window]
[in a new window]
  		Fig. 6. Effect of growth hormone (GH) on plasma leptin in late pregnancy and in early lactation. Twelve multiparous cows were studied in the period between 5 wk before and 5 wk after parturition (weeks -5 to +5 relative to parturition). Cows were randomly allocated to remain untreated (control) or to receive 3 consecutive daily injections of GH (45 mg/injection) in each of weeks -5, -2, +1, and +5 (GH). During each week, blood samples were obtained immediately before (day 0) and the day after a 3-day period of GH injection (day 4). Blood samples were obtained at similar times from the control group. The plasma leptin concentration was analyzed for each sample by RIA. Top: profile of plasma leptin under basal conditions (day 0). Bottom: response in plasma leptin ({Delta}leptin) and insulin ({Delta}insulin). For each group, the response was calculated as the plasma concentration difference between day 4 and day 1. The only significant effect was an interaction between treatment and time (GH x TIME) for {Delta}insulin. This was the result of significant increases in plasma insulin in the GH-treated cows during weeks -5 and -2. During these 2 weeks, basal concentrations (day 0) for plasma insulin were 1.0 ± 0.2 and 1.5 ± 0.2 ng/ml, respectively.

 


   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
DISCLOSURES
 REFERENCES
 
In dairy cattle, the transition from pregnancy to lactation is associated with a reduction in plasma leptin (8, 31, 33). In other species, placental synthesis of leptin (primates) or a soluble form of the leptin receptor (mice) contributes to elevated plasma leptin during pregnancy (21, 25). However, the ruminant placenta, including that of cattle, does not synthesize leptin (15). Moreover, leptin binding activity is negligible when plasma from pregnant cows is incubated with 125I-leptin and assayed by native PAGE or by gel filtration chromatography (R. A. Ehrhardt and Y. R. Boisclair, unpublished results). Instead, we have attributed the periparturient decline in plasma leptin to inhibition of AT leptin synthesis associated with the negative EB of EL (8). This reasoning is supported by three lines of evidence. First, the periparturient decline in plasma leptin is correlated with the onset of negative EB (8, 33). Second, AT leptin gene expression is reduced in EL (8, 47). Finally, when not milked after parturition, dairy cows remain in positive EB and their plasma leptin concentration is identical to that of dairy cows in LP (8).

To understand the regulation of leptin in periparturient dairy cows, we focused on insulin. Insulin stimulates leptin synthesis in rodent and human AT (1, 12) and, unlike other positive regulatory hormones (e.g., prolactin and glucocorticoids), its plasma concentration is decreased markedly in early lactating dairy cows (6, 8). In support of a role for insulin, we show that physiological elevations in plasma concentration increased circulating leptin in both late pregnant and early lactating cows. In both states, plasma leptin responses to insulin took nearly 24 h to plateau. Similar sluggish responses have been observed in humans when euglycemic clamps were performed at modest hyperinsulinemia (42). The slow kinetics of this response may explain why others failed to detect positive effects of insulin in ruminants after acute or short-term elevations in plasma insulin (20, 32). Despite this slow response, we believe the effects of insulin to be direct because insulin alone stimulates indexes of leptin synthesis in ruminant AT explants (28) and because in vivo leptin responses are accelerated considerably when clamps are performed at supraphysiological concentrations of insulin (4, 48).

At steady state, the plasma leptin response to insulin was six times greater in LP than in EL (2.4 vs. 0.4 ng/ml). Insulin infusion produced similar absolute increases in plasma insulin in LP and EL cows, indicating a similar half-life in both states. However, the degree of hyperinsulinemia during lactation was slightly lower, reflecting lower endogenous insulin secretion. This factor alone is unlikely to account for the muted leptin response during EL. First, an eightfold increase in plasma insulin in EL cows produced only a marginally larger response (0.6 ng/ml; W. R. Butler and Y. R. Boisclair, unpublished results). Similarly small leptin responses were observed in two 96-h clamps performed in later lactating dairy cows (0.4 and 0.8 ng/ml) even though their hyperinsulinemia exceeded that achieved in LP in the present study (6.8 and 11.5 vs. 4.0 ng/ml; Ref. 9). Second, insulin-dependent glucose uptake is impaired in early lactating ruminants (7, 50), and recent evidence in other species indicates that glucose uptake is a primary determinant of AT leptin synthesis (36, 38). In humans, the plasma leptin response during hypo- and euglycemic clamp experiments is more closely related to glucose infusion rates than either glucose or insulin concentration (53). Glucose exerts these effects by increasing the production of metabolites such as UDP-N-acetylglucosamine, which sense the energy status of the adipocyte, and stimulates leptin synthesis accordingly (12, 13, 54). Whether the reduced plasma leptin response in EL relates to decreased AT glucose uptake and production of UDP-N-acetylglucosamine remains to be demonstrated in ruminants.

GH inhibits insulin-mediated glucose uptake by AT (19), and the impaired insulin stimulation of glucose disposal in EL coincides with increased GH secretion (7, 8, 51). Moreover, elevated plasma leptin levels seen in GH-deficient humans are corrected by GH therapy, even before a reduction in adiposity occurs (2, 17). These observations prompted us to ask whether GH is a negative regulator of plasma leptin in dairy cows during the periparturient period. We found that exogenous GH treatment did not reduce plasma leptin, either in EL when the plasma concentration of insulin was unaltered or in LP when its concentration was increased by one- to twofold. These results suggest that GH has no independent effect but inhibits insulin-mediated leptin synthesis, an interpretation supported by identical observations in bovine AT explants (28). Our results in LP, however, are in contrast to those obtained in GH-treated castrate male cattle, which experience simultaneous increases in plasma insulin and AT leptin gene expression (28). The reason for this discrepancy is unclear, but it could relate to the pregnant state of our nonlactating cows. Finally, {beta}-adrenergic signaling inhibits both basal and insulin-mediated leptin secretion in rodent adipocytes (11, 23). In EL, ruminant AT displays increased {beta}-adrenergic responsiveness (6, 51), suggesting that this system could also contribute to the reduction of plasma leptin after parturition.

As reported for other species, we found significant concentrations of immunoreactive leptin in bovine milk (3, 18, 27, 46). Consistent with the possibility that most of the leptin in milk is synthesized by the mammary gland, milk leptin concentration is substantially greater than, and not correlated with, the plasma leptin concentration. Bonnet et al. (10) recently showed that, in sheep, mammary leptin gene expression is highest during the first 80 days of gestation, before declining during the remainder of gestation and during EL. By immunohistochemistry, they mapped leptin expression to differentiating epithelial cells during late gestation and to myoepithelial cells during lactation, a surprising finding given the high leptin content of milk. In contrast, we show that leptin gene expression is significant in mammary epithelial cells, suggesting that they synthesize a significant fraction of milk leptin in lactating dairy cows. In agreement with our findings, mammary epithelial cells from mice and humans have been shown to synthesize leptin (3, 46). Smith and Sheffield (44) reported that insulin and IGF-I stimulated leptin mRNA in a bovine mammary epithelial cell line (MAC-T). However, we did not detect increased leptin secretion in milk during the clamp, despite chronic increases in both insulin (Fig. 1) and IGF-I (R. P. Rhoads and Y. R. Boisclair, unpublished results). These data indicate that, if they exist, the positive effects of both insulin and IGF-I on mammary leptin synthesis must be small.

Exogenous leptin administration reduces voluntary feed intake in most animals, and this effect usually requires 2-4 days of continuous treatment in ruminants (24, 37). Chronic hyperinsulinemic-euglycemic clamps often reduce feed intake in lactating dairy cows (22, 35), but our data do not support a role for leptin in this effect. In the present study, feed intake was unaffected in LP, when the insulin-dependent response in plasma leptin was the highest, and depressed in EL, when the leptin response was small. We have noted a similar lack of association between the depression in feed intake and increased plasma leptin in other clamp studies performed in early and in later lactation [Ref. 9 and Y. R. Boisclair, unpublished data]. This lack of association is also inconsistent with the idea that a decrease in plasma leptin around parturition drives the hyperphagia of EL. This notion has been experimentally dispelled in rodents by showing that feed intake varies in proportion to litter size but independently of serum leptin concentration (14, 49). Moreover, the transition from pregnancy to lactation is not associated with increased leptin resistance in rodents (30, 49). As we (8) and others (49) have suggested, the hypoleptinemia of EL may serve to increase energy conservation by suppressing functions that are dispensable in the short term (e.g., reproduction and immunity) and by promoting increased metabolic efficiency. The lactating dairy cow, with its substantial energy deficit of EL, is an ideal model to determine the role that leptin plays in these adaptations.


   DISCLOSURES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
REFERENCES
 
This work was supported by the U.S. Department of Agriculture National Research Initiative Competitive Grant Program (Award 00-35206-9352 to Y. R. Boisclair) and by the Cornell University Agricultural Experiment Station.


   ACKNOWLEDGMENTS
 
The authors thank Debra Dwyer and Ramona Ehrhardt for analysis of hormones and metabolites and Dr. Elvina Matitashvili for the isolation of mammary epithelial cells.


   FOOTNOTES
 

Address for reprint requests and other correspondence: Y. R. Boisclair, 259 Morrison Hall, Dept. of Animal Science, Cornell Univ., Ithaca, NY 14853-4801 (E-mail: YRB1{at}Cornell.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 

  1. Ahima RS and Flier JS. Leptin. Annu Rev Physiol 62: 413-437, 2000.[ISI][Medline]
  2. Ahmad AM, Guzder R, Wallace AM, Thomas J, Fraser WD, and Vora JP. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement. J Clin Endocrinol Metab 86: 3499-3506, 2001.[Abstract/Free Full Text]
  3. Aoki N, Kawamura M, and Matsuda T. Lactation-dependent down regulation of leptin production in mouse mammary gland. Biochim Biophys Acta 1427: 298-306, 1999.[Medline]
  4. Asakuma S, Morishita H, Sugino T, Kurose Y, Kobayashi S, and Terashima Y. Circulating leptin response to feeding and exogenous infusion of insulin in sheep exposed to thermoneutral and cold environments. Comp Biochem Physiol A Mol Integr Physiol 134: 329-335, 2003.[Medline]
  5. Bauman DE and Currie WB. Partitioning of nutrients during pregnancy and lactation: a review of mechanisms involving homeostasis and homeorhesis. J Dairy Sci 63: 1514-1529, 1980.[Abstract/Free Full Text]
  6. Bell AW. Regulation of organic nutrient metabolism during transition from late pregnancy to early lactation. J Anim Sci 73: 2804-2819, 1995.[Abstract]
  7. Bell AW and Bauman DE. Adaptations of glucose metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 2: 265-278, 1997.[Medline]
  8. Block SS, Butler WR, Ehrhardt RA, Bell AW, Van Amburgh ME, and Boisclair YR. Decreased concentration of plasma leptin in periparturient dairy cows is caused by negative energy balance. J Endocrinol 171: 339-348, 2001.[Abstract]
  9. Block SS, Rhoads RP, Bauman DE, Ehrhardt RA, McGuire MA, Crooker BA, Griinari JM, Mackle TR, Weber WJ, Van Amburgh ME, and Boisclair YR. Demonstration of a role for insulin in the regulation of leptin in lactating dairy cows. J Dairy Sci. In press.
  10. Bonnet M, Gourdou I, Leroux C, Chilliard Y, and Djiane J. Leptin expression in the ovine mammary gland: putative sequential involvement of adipose, epithelial, and myoepithelial cells during pregnancy and lactation. J Anim Sci 80: 723-728, 2002.[Abstract/Free Full Text]
  11. Cammisotto PG and Bukowiecki LJ. Mechanisms of leptin secretion from white adipocytes. Am J Physiol Cell Physiol 283: C244-C250, 2002.[Abstract/Free Full Text]
  12. Considine RV. Regulation of leptin production. Rev Endocr Metab Disord 2: 357-363, 2001.[Medline]
  13. Considine RV, Cooksey RC, Williams LB, Fawcett RL, Zhang P, Ambrosius WT, Whitfield RM, Jones R, Inman M, Huse J, and McClain DA. Hexosamines regulate leptin production in human subcutaneous adipocytes. J Clin Endocrinol Metab 85: 3551-3556, 2000.[Abstract/Free Full Text]
  14. Denis RG, Williams G, and Vernon RG. Regulation of serum leptin and its role in the hyperphagia of lactation in the rat. J Endocrinol 176: 193-203, 2003.[Abstract]
  15. Ehrhardt RA, Bell AW, and Boisclair YR. Spatial and developmental regulation of leptin in fetal sheep. Am J Physiol Regul Integr Comp Physiol 282: R1628-R1635, 2002.[Abstract/Free Full Text]
  16. Ehrhardt RA, Slepetis RM, Van Amburgh ME, Siegal-Willot J, Bell AW, and Boisclair YR. Development of a specific RIA to measure physiological changes of circulating leptin in cattle and sheep. J Endocrinol 166: 519-528, 2000.[Abstract]
  17. Elimam A, Lindgren AC, Norgren S, Kamel A, Skwirut C, Bang P, and Marcus C. Growth hormone treatment downregulates serum leptin levels in children independent of changes in body mass index. Horm Res 52: 66-72, 1999.[ISI][Medline]
  18. Estienne MJ, Harper AF, Barb CR, and Azain MJ. Concentrations of leptin in serum and milk collected from lactating sows differing in body condition. Domest Anim Endocrinol 19: 275-280, 2000.[ISI][Medline]
  19. Etherton TD and Bauman DE. Biology of somatotropin in growth and lactation of domestic animals. Physiol Rev 78: 745-761, 1998.[Abstract/Free Full Text]
  20. Gabai G, Cozzi G, Rosi F, Andrighetto I, and Bono G. Glucose or essential amino acid infusions in late pregnant and early lactating Simmenthal cows failed to induce a leptin response. J Vet Med A Physiol Pathol Clin Med 49: 73-80, 2002.[ISI][Medline]
  21. Gavrilova O, Barr V, Marcus-Samuels B, and Reitman M. Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J Biol Chem 272: 30546-30551, 1997.[Abstract/Free Full Text]
  22. Griinari JM, McGuire MA, Dwyer DA, Bauman DE, and Palmquist DL. Role of insulin in the regulation of milk fat synthesis in dairy cows. J Dairy Sci 80: 1076-1084, 1997.[Abstract]
  23. Hardie LJ, Guilhot N, and Trayhurn P. Regulation of leptin production in cultured mature white adipocytes. Horm Metab Res 28: 685-689, 1996.[ISI][Medline]
  24. Henry BA, Goding JW, Alexander WS, Tilbrook AJ, Canny BJ, Dunshea F, Rao A, Mansell A, and Clarke IJ. Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology 140: 1175-1182, 1999.[Abstract/Free Full Text]
  25. Henson MC, Swan KF, and O'Neil JS. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet Gynecol 92: 1020-1028, 1998.[Abstract]
  26. Houseknecht KL, Dwyer DA, Lanna DPD, and Bauman DE. Effect of somatotropin on adipose tissue metabolism: ontogeny of the enhanced response to adrenergic challenge in the lactating cow. Domest Anim Endocrinol 12: 105-113, 1995.[ISI][Medline]
  27. Houseknecht KL, McGuire MK, Portocarrero CP, McGuire MA, and Beerman K. Leptin is present in human milk and is related to maternal plasma leptin concentration and adiposity. Biochem Biophys Res Commun 240: 742-747, 1997.[ISI][Medline]
  28. Houseknecht KL, Portocarrero CP, Ji S, Lemenager R, and Spurlock ME. Growth hormone regulates leptin gene expression in bovine adipose tissue: correlation with adipose IGF-1 expression. J Endocrinol 164: 51-57, 2000.[Abstract]
  29. Ingvartsen KL and Boisclair YR. Leptin and the regulation of food intake, energy homeostasis and immunity with special focus on periparturient ruminants. Domest Anim Endocrinol 21: 215-250, 2001.[ISI][Medline]
  30. Johnstone LE and Higuchi T. Food intake and leptin during pregnancy and lactation. Prog Brain Res 133: 215-227, 2001.[Medline]
  31. Kadokawa H, Blache D, Yamada Y, and Martin GB. Relationships between changes in plasma concentrations of leptin before and after parturition and the timing of first post-partum ovulation in high-producing Holstein dairy cows. Reprod Fertil Dev 12: 405-411, 2000.[Medline]
  32. Kauter K, Ball M, Kearney P, Tellam R, and McFarlane JR. Adrenaline, insulin and glucagon do not have acute effects on plasma leptin levels in sheep: development and characterisation of an ovine leptin ELISA. J Endocrinol 166: 127-135, 2000.[Abstract]
  33. Liefers SC, Veerkamp RF, te Pas MF, Delavaud C, Chilliard Y, and van der Lende T. Leptin concentrations in relation to energy balance, milk yield, intake, live weight, and estrus in dairy cows. J Dairy Sci 86: 799-807, 2003.[Abstract/Free Full Text]
  34. Matitashvili E and Bauman DE. Culture of primary bovine mammary epithelial cells. In Vitro Cell Dev Biol Anim 35: 431-434, 1999.[ISI][Medline]
  35. McGuire MA, Dwyer DA, Harrell RJ, and Bauman DE. Insulin regulates circulating insulin-like growth factors and some of their binding proteins in lactating cows. Am J Physiol Endocrinol Metab 269: E723-E730, 1995.[Abstract/Free Full Text]
  36. Moreno-Aliaga MJ, Stanhope KL, and Havel PJ. Transcriptional regulation of the leptin promoter by insulin-stimulated glucose metabolism in 3t3-l1 adipocytes. Biochem Biophys Res Commun 283: 544-548, 2001.[ISI][Medline]
  37. Morrison CD, Daniel JA, Holmberg BJ, Djiane J, Raver N, Gertler A, and Keisler DH. Central infusion of leptin into well-fed and undernourished ewe lambs: effects on feed intake and serum concentrations of growth hormone and luteinizing hormone. J Endocrinol 168: 317-324, 2001.[Abstract]
  38. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, Stern JS, and Havel PJ. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139: 551-558, 1998.[Abstract/Free Full Text]
  39. National Research Council. Nutrient Requirements of Dairy Cattle (6th rev. ed.). Washington, DC: National Academy Press, 1989.
  40. Neville MC, McFadden TB, and Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 7: 49-66, 2002.[ISI][Medline]
  41. Rhoads RP, Greenwood PL, Bell AW, and Boisclair YR. Organization and regulation of the gene encoding the sheep acid-labile subunit of the 150-kilodalton insulin-like growth factor-binding protein complex. Endocrinology 141: 1425-1433, 2000.[Abstract/Free Full Text]
  42. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, and Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes 47: 544-549, 1998.[Abstract]
  43. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, and Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.[Medline]
  44. Smith JL and Sheffield LG. Production and regulation of leptin in bovine mammary epithelial cells. Domest Anim Endocrinol 22: 145-154, 2002.[ISI][Medline]
  45. Smith MS and Grove KL. Integration of the regulation of reproductive function and energy balance: lactation as a model. Front Neuroendocrinol 23: 225-256, 2002.[ISI][Medline]
  46. Smith-Kirwin SM, O'Connor DM, De Johnston J, Lancey ED, Hassink SG, and Funanage VL. Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 83: 1810-1813, 1998.[Abstract/Free Full Text]
  47. Sorensen A, Adam CL, Findlay PA, Marie M, Thomas L, Travers MT, and Vernon RG. Leptin secretion and hypothalamic neuropeptide and receptor gene expression in sheep. Am J Physiol Regul Integr Comp Physiol 282: R1227-R1235, 2002.[Abstract/Free Full Text]
  48. Utriainen T, Malmstrom R, Makimattila S, and Yki-Jarvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes 45: 1364-1366, 1996.[Abstract]
  49. Vernon RG, Denis RG, Sorensen A, and Williams G. Leptin and the adaptations of lactation in rodents and ruminants. Horm Metab Res 34: 678-685, 2002.[ISI][Medline]
  50. Vernon RG, Faulkner A, Hay WW Jr, Calvert DT, and Flint DJ. Insulin resistance of hind-limb tissues in vivo in lactating sheep. Biochem J 270: 783-786, 1990.[ISI][Medline]
  51. Vernon RG and Pond CM. Adaptations of maternal adipose tissue to lactation. J Mammary Gland Biol Neoplasia 2: 231-241, 1997.[Medline]
  52. Vicini JL, Buonomo FC, Veenhuizen JJ, Miller MA, Clemmons DR, and Collier RJ. Nutrient balance and stage of lactation affect responses of insulin, insulin-like growth factors I and II, and insulin-like growth factor-binding protein 2 to somatotropin administration in dairy cows. J Nutr 121: 1656-1664, 1991.[Abstract/Free Full Text]
  53. Wellhoener P, Fruehwald-Schultes B, Kern W, Dantz D, Kerner W, Born J, Fehm HL, and Peters A. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 85: 1267-1271, 2000.[Abstract/Free Full Text]
  54. Zhang P, Klenk ES, Lazzaro MA, Williams LB, and Considine RV. Hexosamines regulate leptin production in 3T3-L1 adipocytes through transcriptional mechanisms. Endocrinology 143: 99-106, 2002.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/5/R1107    most recent
00320.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leury, B. J.
Right arrow Articles by Boisclair, Y. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leury, B. J.
Right arrow Articles by Boisclair, Y. R.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.